- Page 1/4
- Next Page
Vacuum metrology, where they and one other company have most of the market. Demand increases as we move to increasingly smaller semiconductor nodes. Increase in OLED screens is a positive. They are one of two global players in leak detection, a space that's growing, especially in batteries. A significant position for him.
Displaced Oracle in the cloud as the database of choice. It's about selling cloud services, like a utility. Margins are much higher on cloud than selling software. Over time, margins and free cashflow will go up. Not concerned about the valuation, because of growing business and margins.
Fine company. Merging with a competitor, so this brings uncertainty. Not beholden to any one customer. He owns TXN instead, which does digital and analog chips. One of the most profitable of all of the chip manufacturers, and this is why he owns TXN.
Liked it better in the past than today. If there were a recession, they'd need more capital. Remains a very fine company as to products. Good management that will learn from the past. Volumes in medical devices are not recovering as he expected. He owns Abbott Labs instead, a diversified player with a very strong balance sheet. You could also look at the dental space.
Excellent company. Supplies data to insurance companies. Only risk is consolidation, where insurance companies wouldn't need to buy the data, as they'd have it if they were big enough. A resilient business, so not the best place to be in the first stage of an economic recovery. He prefers a capital goods cyclical right now, such as DE or CAT.
Excellent company. He exited last year after its great run in 2020. Industrial chip space, such as TXN, didn't do as well, so 2021 will be an easier comparison in the short term. Does well when crypto mining does well.
